Howard Higley (contractor to CIP to follow these projects) and Carolyn Sigworth (SSA) and Gary Kelloff

endorsed by FDA as biomarker qualification processes.

2 trials:

• Lymphoma collected by OSU Jacko (therapy)  under 25 cases thus far.
• ACRIN 6678 Lung, run by Weber, PET CT of the Lung (monitoriing rather than therapy) (maybe some IP issues on data)
  

Accrual is not close 

Three-way FNIH project.  Us, FDA, Companies.

These are open trials, need to satisify FNIH "incubation period" security.

Carl will call Higley today.